After Hours
$
1.66
Change
-0.02 -1.19%
Volume
Volume 9,241
Jan 27, 2023, 7:57 p.m.
Quotes are delayed by 20 min
Previous close
$ 1.66
$ 1.68
Change
+0.02 +1.20%
Day low
Day high
$1.64
$1.71

52 week low
52 week high
$1.38
$4.28

Market cap
$419.14M
Average volume
5.12M
P/E ratio
N/A
Rev. per Employee
$34,627
EPS
-1.47
Dividend
N/A
Div yield
N/A
Ex dividend date
N/A
MarketWatch News on INO
-
Inovio Pharmaceuticals Inc. stock outperforms competitors on strong trading day
- MarketWatch Automation
-
Inovio Pharmaceuticals Inc. stock falls Thursday, underperforms market
- MarketWatch Automation
-
Inovio Pharmaceuticals Inc. stock remains steady Wednesday, still outperforms market
- MarketWatch Automation
-
Inovio Pharmaceuticals Inc. stock rises Tuesday, outperforms market
- MarketWatch Automation
-
Inovio Pharmaceuticals Inc. stock falls Monday, underperforms market
- MarketWatch Automation
-
Inovio Pharmaceuticals Inc. stock falls Thursday, underperforms market
- MarketWatch Automation
-
Inovio Pharmaceuticals Inc. stock underperforms Wednesday when compared to competitors
- MarketWatch Automation
-
Inovio Pharmaceuticals Inc. stock underperforms Tuesday when compared to competitors
- MarketWatch Automation
-
Inovio Pharmaceuticals Inc. stock falls Friday, underperforms market
- MarketWatch Automation
-
Inovio Pharmaceuticals Inc. stock outperforms market on strong trading day
- MarketWatch Automation
-
Inovio Pharmaceuticals Inc. stock rises Wednesday, outperforms market
- MarketWatch Automation
-
Inovio Pharmaceuticals Inc. stock rises Tuesday, outperforms market
- MarketWatch Automation
-
Inovio Pharmaceuticals Inc. stock outperforms market on strong trading day
- MarketWatch Automation
-
Inovio Pharmaceuticals Inc. stock remains steady Friday, underperforms market
- MarketWatch Automation
-
Inovio Pharmaceuticals Inc. stock falls Thursday, underperforms market
- MarketWatch Automation
-
Inovio Pharmaceuticals Inc. stock rises Wednesday, outperforms market
- MarketWatch Automation
-
Inovio Pharmaceuticals Inc. stock underperforms Tuesday when compared to competitors
- MarketWatch Automation
-
Inovio Pharmaceuticals Inc. stock outperforms competitors on strong trading day
- MarketWatch Automation
-
Inovio Pharmaceuticals Inc. stock rises Thursday, outperforms market
- MarketWatch Automation
-
Inovio Pharmaceuticals Inc. stock rises Wednesday, outperforms market
- MarketWatch Automation
- Loading more headlines...
Analyst Ratings
Other News on INO
-
10-Q: INOVIO PHARMACEUTICALS, INC.
- Edgar Online - (EDG = 10Q, 10K)
-
Inovio Pharmaceuticals Q3 2022 Earnings Preview
- Seeking Alpha
-
Notable earnings after Tuesday's close
- Seeking Alpha
-
Amazon.com, Pinduoduo, JD.com among premarket losers' pack
- Seeking Alpha
-
Inovio Pharmaceuticals: Catalysts On The Horizon
- Seeking Alpha
-
Moderna, Novavax hit 52-week lows
- Seeking Alpha
-
Inovio Pharmaceuticals: Long On Promise, Short On Results
- Seeking Alpha
-
1 Green Flag and 1 Red Flag For Inovio Pharmaceuticals
- Motley Fool
-
Why Inovio Pharmaceuticals Is Gaining Today
- Motley Fool
- Loading more headlines...
Press Releases on INO
-
Vaccine Market Research Report: Growth, Top Companies Share, Size, and Forecast 2022-2027
- SUPER MARKET RESEARCH
-
INOVIO Provides an Update on Lassa Fever and MERS Programs
- PR Newswire - PRF
-
While COVID-19 Drags On, Biotechs Introduce New Treatments & Vaccines to Combat Subvariants
- Financial News Media
-
INOVIO Reports Financial Results and Highlights for the Third Quarter 2022
- PR Newswire - PRF
-
INOVIO to Report Third Quarter 2022 Financial Results on November 8, 2022
- PR Newswire - PRF
-
Vaccine Market 2022-2027: Industry Report, Growth, Demand, Key Players And Forecast
- SUPER MARKET RESEARCH
-
INOVIO Reports Inducement Grants Under Inducement Plan
- PR Newswire - PRF
-
INOVIO Reports Financial Results and Highlights for the Second Quarter 2022
- PR Newswire - PRF
-
INOVIO to Report Second Quarter 2022 Financial Results on August 9, 2022
- PR Newswire - PRF
-
INOVIO Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
- PR Newswire - PRF
-
INOVIO Appoints Dr. Michael Sumner, MB BS, MBA as Chief Medical Officer
- PR Newswire - PRF
- Loading more headlines...
Rates »
National averages from Bankrate.com
National averages from Bankrate.com
National averages from Bankrate.com